Transfusion not superior to no transfusion at an Hbg of 7.0 g/dL in critically ill patients: Study
Evaluation of transfusion targets other than a haemoglobin threshold of 7.0 G/dl may be warranted, according to a recent study published in the Annals of the American Thoracic Society.
In critically ill patients, a haemoglobin transfusion threshold of <7.0 G/dl compared to <10.0 G/dl improves organ dysfunction. However, it is unclear if transfusion at a haemoglobin of <7.0 g/dL is superior to no transfusion.
A group of researchers conducted a study to compare levels of organ dysfunction between transfusion and no transfusion at a haemoglobin threshold of <7.0 G/dl among critically ill patients using quasi-experimental regression discontinuity methods.
Researchers performed regression discontinuity analysis using haemoglobin measurements from patients admitted to ICUs in three cohorts (MIMIC-IV, eICU, and Premier Inc.), estimating the change in organ dysfunction (modified sequential organ failure assessment score) in the 24–72-hour window following each haemoglobin measurement.
They compared haemoglobin levels just above and below 7.0 g/dL using a 'fuzzy' discontinuity approach, based on the concept that measurement noise pseudorandomizes similar haemoglobin levels on either side of the transfusion threshold. Results: A total of 11,181, 13,664, and 167,142 patients were included in the MIMIC-IV, eICU, and Premier cohorts, respectively. Patient characteristics below the threshold did not differ from those above the threshold, except that crossing below the threshold resulted in a >20% absolute increase in transfusion rates in all three cohorts. Transfusion was associated with increases in hemoglobin level in the subsequent 24-72 hours (MIMIC-IV 2.4 [95% CI 1.1, 3.6] g/dL; eICU 0.7 [95% CI 0.3, 1.2] g/dL; Premier 1.9 [95% CI 1.5, 2.2] g/dL), but not with improvement in organ dysfunction (MIMIC-IV 4.6 [95% CI -1.2, 10] points; eICU 4.4 [95% CI 0.9, 7.8] points; Premier 1.1 [95% CI -0.2, 2.3] points), compared to no transfusion.
Thus, the researchers concluded that transfusion was not associated with improved organ dysfunction compared to no transfusion at a haemoglobin threshold of 7.0 g/dL, suggesting that evaluation of transfusion targets other than a haemoglobin threshold of 7.0 G/dl may be warranted.
Reference:
Red Blood Cell Transfusion at a Hemoglobin Threshold of Seven g/dL in Critically Ill Patients: A Regression Discontinuity Study by Nicholas A Bosch, et al. published in the Annals of the American Thoracic Society.
https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.202109-1078OC
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.